IRulya Therapeutics Inc. (IRLA) KPIs and segments

IRLANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/30

$39.80+0.02 (+0.05%)

Close on Nov 13, 2026Market cap $40.48MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive IRulya Therapeutics's business

Coming soon

This tab will track the numbers specific to IRulya Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?